NCT02639975View on ClinicalTrials.gov

"First-in-human Study To Assess the Safety and Tolerability of PBF-677 in Healthy Volunteers"

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

April 30, 2016

Study Completion Date

June 30, 2016

Conditions
Glaucoma
Interventions
DRUG

PBF-677

once daily oral administration

DRUG

Placebo

once daily oral administration

All Listed Sponsors
lead

Palobiofarma SL

INDUSTRY

NCT02639975 - "First-in-human Study To Assess the Safety and Tolerability of PBF-677 in Healthy Volunteers" | Biotech Hunter | Biotech Hunter